News Agency News Aggregator Journalist/Editor Broking House Others
GLENMARK - Statement Of Investor Complaints For The Quarter Ended June 2020
COVID drugs picture. HCQS - made by many, no patent (ipca up 20-40%) Avigan - Fujifilm Japan, licensed by glenmark (up 40%) Remdesivir - Gilead, licensed by jubilant up 60%) Itolizumab - Biocon's own drug, licensed by Equillium (stock up 700% on NYSE). Biocon just 4% up yet.
Glenmark Pharma has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu to closely monitor the efficacy and safety of the drug in 1000 patients that are prescribed with the oral antiviral, as part of an open-label. #MOMarketUpdates
14th July Strategy: 7 Stocks In F&O Ban: New Entry: SAIL, Escorts Already in Ban: Glenmark, Century Textiles, Vodafone Idea, PNB, Equitas Out of Ban: BHEL Stock Of the Day: Buy BF Utilities: SL 195, TGT 210, 215, 220 RK Damani bought a 1.3% stake in June quarter @ZeeBusiness
STOCK specific trades:: #NTPC #Cipla #Powergrid #ONGC #Sunpharma #DRREDDY #Glenmark positive trend expected .......
sets price band between Rs12-Rs13, Glenmark announces price reduction of 27% for oral antiviral drug FabiFlu, Google Announces $10B Google for India Digitization Fund next 5-7 years. #MOMarketUpdates
Business Standard Ø Double-digit decline for PepsiCo's India revenue amid Covid-19 crisis Ø IT Services Sector's Revenues may contract up to 3% in FY21: ICRA Ø Glenmark cuts price of Covid drug FabiFlu by 27% within a month of launch✅
EVENTS Results Today: Wipro, Mindtree, Hindustan Copper Q4, Century Textiles, Delta, National Peroxide Q4, Khadim Q4, Oberoi Realty Other: WPI Inflation, Japan Industrial Production, OPEC Monthly report In Ban: SAIL, CENTURYTEX, EQUITAS, GLENMARK, IDEA, PNB, ESCORTS
F&O #BAN New in Ban: ESCORTS, SAIL Still in Ban: CENTURYTEX, EQUITAS, GLENMARK, IDEA, PNB Out of Ban: BHEL @CNBC_Awaaz #AwaazMarkets
Headlines at 8 pm | Biocon rallies after Itolizumab becomes the first indigenous drug, and the fifth overall, to receive regulatory approval for emergency use to treat COVID-19. Glenmark cuts the price of its COVID-19 drug Favipiravir by 27%
COVID-19 Medicine Price Reduces by Glenmark Pharma Read more: #latestnews #MedicinePriceReduces #GlenmarkPharma